B Barlogie

2.4k total citations
23 papers, 1.5k citations indexed

About

B Barlogie is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, B Barlogie has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in B Barlogie's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). B Barlogie is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). B Barlogie collaborates with scholars based in United States. B Barlogie's co-authors include Raymond Alexanian, Joshua Epstein, P Selvanayagam, Hagop M. Kantarjian, EJ Freireich, KB McCredie, Lon Smith, L Smallwood, J A Katzmann and A Goodacre and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The American Journal of Medicine.

In The Last Decade

B Barlogie

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Barlogie United States 16 1.1k 655 561 429 242 23 1.5k
A Kuramoto Japan 12 824 0.7× 377 0.6× 280 0.5× 387 0.9× 107 0.4× 28 1.2k
PR Greipp United States 21 1.6k 1.4× 1.5k 2.3× 550 1.0× 781 1.8× 126 0.5× 33 2.3k
RA Kyle United States 19 1.5k 1.3× 1.7k 2.6× 638 1.1× 753 1.8× 185 0.8× 30 2.4k
Hugh D Carr-Smith United Kingdom 10 912 0.8× 1.1k 1.7× 364 0.6× 363 0.8× 100 0.4× 14 1.6k
James D. Cavenagh United Kingdom 17 901 0.8× 578 0.9× 244 0.4× 391 0.9× 91 0.4× 48 1.3k
Carlos Bueso-Ramos United States 18 1.0k 0.9× 750 1.1× 572 1.0× 208 0.5× 192 0.8× 37 1.7k
Carolina Terragna Italy 25 1.8k 1.6× 1.2k 1.9× 354 0.6× 885 2.1× 187 0.8× 99 2.3k
Gösta Gahrton Sweden 5 1.2k 1.1× 925 1.4× 616 1.1× 708 1.7× 372 1.5× 7 1.8k
FR Davey United States 14 1.1k 1.0× 372 0.6× 391 0.7× 266 0.6× 227 0.9× 32 1.6k
JM Cayuela France 19 887 0.8× 519 0.8× 348 0.6× 250 0.6× 147 0.6× 24 1.4k

Countries citing papers authored by B Barlogie

Since Specialization
Citations

This map shows the geographic impact of B Barlogie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Barlogie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Barlogie more than expected).

Fields of papers citing papers by B Barlogie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Barlogie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Barlogie. The network helps show where B Barlogie may publish in the future.

Co-authorship network of co-authors of B Barlogie

This figure shows the co-authorship network connecting the top 25 collaborators of B Barlogie. A scholar is included among the top collaborators of B Barlogie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Barlogie. B Barlogie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zangari, Maurizio, Fariba Saghafifar, Paulette Mehta, et al.. (2003). The Blood Coagulation Mechanism in Multiple Myeloma. Seminars in Thrombosis and Hemostasis. 29(3). 275–282. 65 indexed citations
3.
Barlogie, B. (2001). Thalidomide in the management of multiple myeloma. Seminars in Oncology. 28(6). 577–582. 42 indexed citations
4.
Shaughnessy, John D. & B Barlogie. (2001). Developmental therapeutics for multiple myeloma—A road map for the future. Seminars in Hematology. 38(3). 295–297. 2 indexed citations
5.
Barlogie, B, et al.. (1994). Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma*. Journal of Hematotherapy. 3(2). 149–153. 3 indexed citations
6.
Dimopoulos, Meletios Α., Susan O’Brien, Hagop M. Kantarjian, et al.. (1993). Fludarabine therapy in Waldenström's macroglobulinemia. The American Journal of Medicine. 95(1). 49–52. 84 indexed citations
7.
Barlogie, B & Robert Peter Gale. (1992). Multiple myeloma and chronic lymphocytic leukemia: Parallels and contrasts. The American Journal of Medicine. 93(4). 443–450. 16 indexed citations
8.
Alexanian, Raymond, Meletios Α. Dimopoulos, Kay Delasalle, & B Barlogie. (1992). Primary dexamethasone treatment of multiple myeloma. Blood. 80(4). 887–890. 22 indexed citations
9.
Barlogie, B & Joshua Epstein. (1990). Multiple myeloma: biology and therapy. Journal of Cancer Research and Clinical Oncology. 116(1). 109–111. 4 indexed citations
10.
Marchetti, Dario, Nguyen T. Van, Bahiru Gametchu, et al.. (1989). Flow cytometric analysis of glucocorticoid receptor using monoclonal antibody and fluoresceinated ligand probes.. PubMed. 49(4). 863–9. 17 indexed citations
11.
Barlogie, B, Joshua Epstein, P Selvanayagam, & Raymond Alexanian. (1989). Plasma cell myeloma--new biological insights and advances in therapy. Blood. 73(4). 865–879. 250 indexed citations
12.
Barlogie, B, Joshua Epstein, P Selvanayagam, & Raymond Alexanian. (1989). Plasma cell myeloma--new biological insights and advances in therapy. Blood. 73(4). 865–879. 218 indexed citations
13.
Keating, MJ, Hagop M. Kantarjian, Moshe Talpaz, et al.. (1989). Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood. 74(1). 19–25. 216 indexed citations
14.
Kantarjian, HM, et al.. (1988). Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood. 72(5). 1784–1789. 64 indexed citations
15.
16.
Barlogie, B, Raymond Alexanian, L Smallwood, et al.. (1988). Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]. Blood. 72(6). 2015–2019. 55 indexed citations
17.
Epstein, Joshua, B Barlogie, J A Katzmann, & Raymond Alexanian. (1988). Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood. 71(4). 861–865. 93 indexed citations
18.
Selvanayagam, P, Mark Blick, Franco Narni, et al.. (1988). Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood. 71(1). 30–35. 6 indexed citations
19.
Barlogie, B, Raymond Alexanian, Mark A. Pershouse, L Smallwood, & Lon Smith. (1985). Cytoplasmic immunoglobulin content in multiple myeloma.. Journal of Clinical Investigation. 76(2). 765–769. 62 indexed citations
20.
Barlogie, B, et al.. (1985). Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood. 66(2). 338–341. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Kuramoto Breakdown of academic impact, for papers by PR Greipp Breakdown of academic impact, for papers by RA Kyle Breakdown of academic impact, for papers by Hugh D Carr-Smith Breakdown of academic impact, for papers by James D. Cavenagh Breakdown of academic impact, for papers by Carlos Bueso-Ramos Breakdown of academic impact, for papers by Carolina Terragna Breakdown of academic impact, for papers by Gösta Gahrton Breakdown of academic impact, for papers by FR Davey Breakdown of academic impact, for papers by JM Cayuela
Rankless by CCL
2026